Taiwan clears VUNO’s AI fundus evaluation device
South Korean agency VUNO has gained the approval of Taiwan’s Meals and Drug Administration to market its AI fundus evaluation software program.
VUNO Med-Fundus AI analyses photographs of the fundus to shortly detect places of lesions indicative of retinal illnesses, together with diabetic retinopathy, macular illness and glaucoma.
This newest certification follows Taiwan FDA’s clearance for its different AI merchandise, VUNO-Med Chest X-ray and VUNO-Med Bone Age. Simply two months in the past, VUNO obtained Singapore‘s clearance for VUNO Med-Fundus AI.
Examine validates AIRS Medical’s AI resolution for denoising 3D MR photographs
AIRS Medical, a medical AI startup from South Korea, has not too long ago proved in a examine the aptitude of its AI-powered MRI reconstruction resolution, SwiftMR, to denoise and significantly enhance the standard of 3D MR photographs.
Primarily based on its findings, a deep neural network-based noise discount and picture high quality enchancment device outperformed the standard magnetisation-prepared fast gradient-echo (MP-RAGE) sequence in bettering MR picture high quality.
“We’re more than happy that we have now proved SwiftMR contributes to not solely decreasing time but additionally [helping] make photographs nice, finally [helping] radiologists learn photographs with confidence,” mentioned AIRS Medical CEO Dr Hyeseong Lee.
Qure.ai packages options utilizing NVIDIA’s MONAI package
Indian well being expertise startup Qure.ai is likely one of the early adopters of NVIDIA’s newest open-source framework for deploying AI medical imaging functions.
The MONAI Software Packages (MAP) simplify the method of deploying an AI mannequin in an present healthcare ecosystem.
Qure.ai is now packaging its AI options for deployment utilizing MAPs, accelerating its medical impression, in response to NVIDIA.
UK-based Cambridge Cognition brings mind well being options to China
London-listed Cambridge Cognition, a supplier of cognitive evaluation check options, has entered into a brand new partnership to convey its digital well being choices to China.
The corporate not too long ago signed a 10-year unique licensing deal and strategic partnership with Luca Healthcare, a neighborhood developer of digital well being evaluation instruments.
Luca shall be making Cambridge Cognition’s CANTAB suite of digital mind well being assessments accessible in China through its LucaPlex platform.
“China has over 265 million folks aged 60 years and above, of which 40 million folks have delicate cognitive impairment and 15 million folks with a type of dementia. With neurodegenerative illnesses, early analysis is the important thing to managing illness development. We’ll leverage Cambridge Cognition’s analysis, scientific know-how, and digital expertise to make accessible superior cognitive evaluation instruments for the medical trials market and the healthcare market in China,” mentioned Luca CEO Echo Chen.
